Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orion Bionetworks MS Project Plumbs Big Data To Revitalize CNS Drug Development

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

A diverse group of public and private institutions has launched a precompetitive data sharing and predictive modeling effort called Orion Bionetworks, using computational biology to sift through imaging, genetic and biologic data from thousands of patients to identify the molecular underpinnings of multiple sclerosis and accelerate the pursuit of cures. Johnson & Johnson provided $5.4 million to fund the project.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS005371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel